Hospira In Australia

Quote
Anonymous said:
I heard the fillers on the floor are not hustling , therefore Tony will add inspection and packing to compensate for lost production Time.You better get used to increased workload with LESS people, LESS pay and LESS respect ! In time the slackers who can't cut it will be gone for good. The good old days are GONE. The dead wood WILL be weeded out and eliminated at EVERY HSP LOCATION !

hr guy
Click to expand...

Just keep working that line, and let Fat Boy reel you in !Hurry,Time is MONEY ! Don't worry about glass particles


HR GUY
:eek: :eek:
 






Anonymous said:
Along with mitoxantrone this is no coincidence ! The unexplained batch discrepancies in aseptic areas show the disregard for public and this is WHY hsp will NEVER
be compliant in all plants for any sustained amount of time

Hr Guy
Click to expand...

January 6, 2015
Hospira ($HSP), which has continued its struggles with manufacturing quality, closed out the year with a recall, and it was a big one. The Illinois-based company issued a worldwide recall of the cancer med mitoxantrone that was manufactured at a plant in Australia that the FDA savaged in a warning letter last year for not figuring out why tests showed its potency was too low and its impurities too high.
The drugmaker now is recalling 10 lots of the drug from the U.S., Canada, the U.K., Ireland, Australia, New Zealand, Cyprus, Saudi Arabia, Qatar, Oman and Bahrain. The recall is for both human and veterinary drugs in various dose sizes. The drug was distributed to hospitals and vet clinics globally starting in February 2013 and through November 2014, Hospira said in a release distributed by the FDA. The FDA said the Lake Forrest, IL, company figured out what caused the issue and addressed the problems for batches manufactured since March 2014.

The drugmaker said there have been no adverse reports from use of the cancer med, but acknowledged there is the potential for it not to be effective because of its subpotency and for patients then to receive additional dosing that could lead to toxin buildup from impurities.
The FDA in September took the drugmaker's plant in Mulgrave, Victoria, to task for not getting to the root cause of out-of-specification results for multiples batches of mitoxantrone, even after customer complaints. There was also a particularly long delay between when it first got word of particles appearing in the chemo drug carboplatin, in May 2012, and when it finally confirmed the issue, in December 2013. Then it was another three months before Hospira gave providers a heads up that they should be watching for particles and should use a filter before administering it, the letter said. The drugmaker has spent years, and hundreds of millions of dollars, working to get serious manufacturing failings at its U.S. plants behind it. And while those plants have improved, it has faced FDA concerns at facilities outside of the U.S. Besides the warning letter for the Australian plant, Hospira has had issues with operations in India, where it is expanding to lower its cost of products. A facility in Irungattukottai was issued a warning letter in May 2013 and then received another 23 observations in a follow-up inspection late that year. Last year, Hospira CEO F. Michael Ball told analysts that after a preapproval inspection of a plant it is building in Vizag, India, the FDA issued a Form 483 with 10 observations.
 






Anonymous said:
I heard the fillers on the floor are not hustling , therefore Tony will add inspection and packing to compensate for lost production Time.You better get used to increased workload with LESS people, LESS pay and LESS respect ! In time the slackers who can't cut it will be gone for good. The good old days are GONE. The dead wood WILL be weeded out and eliminated at EVERY HSP LOCATION !

hr guy
Click to expand...

What do you Mulgrave Grunts and the NUW think about Pfizer acquisition ? Is Big Tony going to big blue

HR
U S A 1
 












Re: Hospira In Australia
new.org.au

Re: Hospira In Australia
nuw.org.au
Interesting Hospira article.
Roll on Friday, love my strike days.

Re: Hospira In Australia
Quote:
Originally Posted by Anonymous
new.org.au
Another uneducated r***** trying to post a URL BUT it takes two attempts
Now you know why Tony has to get the job done for you
 


















Anonymous said:
Abbott old timers aren't worth their weight in shit! When Hpd spun anybody that stayed in leiu
of a package was told flat out its going to be a different situation and if you can't produce you will be terminated It was clearly explained at all levels You were give all the reasons not to stay
because Hospira didn't want lazy overpaid old timers thinking This is still Abbott That's why 51% of personell who stayed are now either fired or forced to retire They weren't lying and you all were warned
HR Guy
Click to expand...
HR Guy is a troll, probably never worked for either company or he would say the ignorant shit he says. I know he never worked for HSP because his facts are all screwed up, for example there were NO packages given, just early retirement for those who had already earned it didn't go to HSP for various reasons (mostly because they were very near retirement already). Some did go to other companies and got their early retirement but they were few. Most of the younger ones who left did so over time for much better jobs at much better companies like Amgen.
 






Anonymous said:
HR Guy is a troll, probably never worked for either company or he would say the ignorant shit he says. I know he never worked for HSP because his facts are all screwed up, for example there were NO packages given, just early retirement for those who had already earned it didn't go to HSP for various reasons (mostly because they were very near retirement already). Some did go to other companies and got their early retirement but they were few. Most of the younger ones who left did so over time for much better jobs at much better companies like Amgen.
Click to expand...

IMO hr guy made a fool out of you many times on here His info is accurate everybody knows
it including you
 






Anonymous said:
We were told to stop following gmp guidelines and let it all be recalled.Its all for naught these buggers who raised hands and we will be remembered after those wankers and fat boy try us
Click to expand...

Matey, you better follow GMP and be compliant If you deliberately and recklessly endanger the public, and it documented, your ass will get locked up ! You are ALL being watched very closely

HR "YANK"
U S A 1
 












Anonymous said:
Along with mitoxantrone this is no coincidence ! The unexplained batch discrepancies in aseptic areas show the disregard for public and this is WHY hsp will NEVER
be compliant in all plants for any sustained amount of time

Hr Guy
Click to expand...

I'm surprised you people didn't jump on the recent FDA letter to Italy Plant

The FDA inspected the Italy manufacturing facility in May. It said the company should have better security protecting data generated during its manufacturing process. The FDA said employees could have deleted or altered raw files produced by some machines and that the company couldn't verify when some files were changed or deleted or who did it.

:eek:Somebody should be fired AND arrested:eek:
 






The Vizag Plant Will take over Pfizer's India's Manufacturing Operations
Hospiras new 1.1-million-square-foot, $450 million plant will handle all the sterile injectable capacity and API manufacturing and R&D Operations
Is Fat Tony and NUW gonna clash

HR

Pfizer ($PFE) intends to close one of its plants in India, a facility that has sat mostly idle for two years. But it is not as if Pfizer will be short on manufacturing capacity in the country. As soon as it completes its $15 billion deal to buy Hospira ($HSP), it will get that company's massive manufacturing network there, including a brand-spanking-new plant in Vizag.Pfizer broke the bad news in a filing Wednesday with the Bombay Stock Exchange. It intends to close its plant at Navi Mumbai by September 16, 2015. Pfizer said there has been practically "no production activity at this plant since 2013, and the closure will not impact the supply of any of the Company's medicines to patients."
 






Top Bottom
Back
Quote